LeanLife Health Inc.
LNLHF · OTC
3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $2 | $5 | $11 | $5 |
| Gross Profit | -$2 | -$5 | -$11 | -$5 |
| % Margin | – | – | – | – |
| R&D Expenses | $112 | $286 | $0 | $0 |
| G&A Expenses | $2,588 | $2,021 | $2,162 | $1,815 |
| SG&A Expenses | $3,634 | $2,403 | $2,442 | $2,233 |
| Sales & Mktg Exp. | $1,046 | $382 | $280 | $418 |
| Other Operating Expenses | -$110 | -$1,001 | $0 | $0 |
| Operating Expenses | $3,636 | $1,688 | $1,828 | $2,238 |
| Operating Income | -$3,421 | -$1,692 | -$1,839 | -$2,360 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$250 | -$720 | -$424 | -$241 |
| Pre-Tax Income | -$3,671 | -$2,074 | -$2,037 | -$2,361 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$3,671 | -$2,074 | -$2,037 | -$2,361 |
| % Margin | – | – | – | – |
| EPS | -0.023 | -0.02 | -0.03 | -0.058 |
| % Growth | -14.9% | 33.3% | 47.8% | – |
| EPS Diluted | -0.023 | -0.02 | -0.03 | -0.058 |
| Weighted Avg Shares Out | 158,097 | 102,795 | 67,174 | 40,669 |
| Weighted Avg Shares Out Dil | 158,097 | 102,795 | 67,174 | 40,669 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $6 | $0 | $1 | $1 |
| Depreciation & Amortization | $2 | $6 | $15 | $5 |
| EBITDA | -$3,421 | -$2,617 | -$2,705 | -$2,355 |
| % Margin | – | – | – | – |